BRIEF-Ignyta to explore strategic options for Taladegib through amendment of Taladegib license agreement with Lilly
March 23, 2017 at 16:44 PM EDT
* Ignyta announces exploration of strategic options for Taladegib, enabled by amendment of Taladegib license agreement with Lilly